2019
DOI: 10.1093/annonc/mdz246.104
|View full text |Cite
|
Sign up to set email alerts
|

Immune status of patients with different stages of colorectal cancer with and without circulating tumour cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…As an immune effector, it can participate in and regulate the humoral immune system of the body, including IgA, IgM and IgG (20). Sitkovskaya et al (21) measured the level of immune cells in patients with colorectal cancer at different stages, and found that CD4+ levels were increased in the early and late stages of the disease. Kim et al ( 22) significantly improved the mental and physical status of patients with colorectal cancer through a family health exercise program.…”
Section: Comparison Of Overall Nursing Satisfactionmentioning
confidence: 99%
“…As an immune effector, it can participate in and regulate the humoral immune system of the body, including IgA, IgM and IgG (20). Sitkovskaya et al (21) measured the level of immune cells in patients with colorectal cancer at different stages, and found that CD4+ levels were increased in the early and late stages of the disease. Kim et al ( 22) significantly improved the mental and physical status of patients with colorectal cancer through a family health exercise program.…”
Section: Comparison Of Overall Nursing Satisfactionmentioning
confidence: 99%
“…When viewed through the lens of heterogeneous tumor architecture, temporal disease states, and diverse and dynamic cellular communities, we can begin to understand the complex changes in NK cell states produced by the sum of these elements. Both preclinical and clinical evidence point to a paradigm of continuous changes in NK cell development and activation over the course of cancer progression ( 1 , 17 , 18 ). Comparisons of NK cell states within the TME from early to advanced disease may provide insight into specific mechanisms that can be targeted to restore antitumor NK cell function in advanced cancers.…”
Section: Introductionmentioning
confidence: 99%